Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale.
Schennach-Wolff
R
R
Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich, Germany. Rebecca.Schennach-Wolff@med.uni-muenchen.de
Obermeier
M
M
Seemüller
F
F
Jäger
M
M
Messer
T
T
Laux
G
G
Pfeiffer
H
H
Naber
D
D
Schmidt
L G
LG
Gaebel
W
W
Klosterkötter
J
J
Heuser
I
I
Maier
W
W
Lemke
M R
MR
Rüther
E
E
Klingberg
S
S
Gastpar
M
M
Möller
H-J
HJ
Riedel
M
M
D000328:Adult; D000367:Age Factors; D016022:Case-Control Studies; D015331:Cohort Studies; D003863:Depression / Q000523:psychology*; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D016015:Logistic Models; D008297:Male; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000628:therapy; D012565:Schizophrenic Psychology; D059020:Suicidal Ideation; D013997:Time Factors; D016896:Treatment Outcome